D
Design Therapeutics, Inc. DSGN
$5.41 $0.214.04% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -61.82% -59.52% -15.28% 17.42% 40.85%
Total Depreciation and Amortization 0.66% 11.19% 7.97% 11.68% 13.53%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 102.08% 69.87% 127.32% 9.55% -25.81%
Change in Net Operating Assets 173.74% 41.79% 181.13% 519.25% -136.75%
Cash from Operations -28.25% -34.97% 22.96% 34.32% 18.43%
Capital Expenditure 45.96% 63.08% 100.00% 130.19% -80.90%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -26.52% -61.84% -67.18% -138.14% 127.77%
Cash from Investing -26.40% -61.83% -67.02% -138.16% 128.12%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 57.64% 15.00% -47.50% -92.31% 9.05%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 57.64% 15.00% -47.50% -92.31% 9.05%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -62.97% -208.53% -15.17% -2,163.22% 1,111.29%